First Hawaiian Bank Acquires 1,164 Shares of Humana Inc. $HUM

First Hawaiian Bank grew its holdings in shares of Humana Inc. (NYSE:HUM) by 9.2% during the first quarter, Holdings Channel reports. The firm owned 13,811 shares of the insurance provider’s stock after purchasing an additional 1,164 shares during the period. First Hawaiian Bank’s holdings in Humana were worth $3,654,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of HUM. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Riverview Trust Co bought a new position in shares of Humana during the 1st quarter valued at $34,000. Garde Capital Inc. bought a new position in shares of Humana during the 1st quarter valued at $36,000. Zions Bancorporation National Association UT bought a new position in shares of Humana during the 1st quarter valued at $37,000. Finally, Whipplewood Advisors LLC raised its holdings in shares of Humana by 639.1% during the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider’s stock valued at $45,000 after purchasing an additional 147 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $279.04 on Friday. The firm’s 50-day moving average is $264.58 and its 200-day moving average is $257.07. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $331.00. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $33.56 billion, a price-to-earnings ratio of 21.42, a PEG ratio of 1.61 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter in the previous year, the firm posted $6.96 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s payout ratio is presently 27.17%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Bank of America raised their price target on shares of Humana from $285.00 to $312.00 and gave the company a “neutral” rating in a report on Tuesday, September 2nd. Truist Financial cut their price target on shares of Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Piper Sandler dropped their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Barclays lifted their target price on shares of Humana from $275.00 to $315.00 and gave the stock an “equal weight” rating in a report on Friday, September 5th. Finally, Wells Fargo & Company dropped their target price on shares of Humana from $348.00 to $344.00 and set an “overweight” rating on the stock in a report on Thursday, August 14th. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $289.24.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.